10.1 DLCO Protocol & Equipment Selection

Why DLCO selection is a scored Domain II skill

On the NBRC Pulmonary Function Technologist Examination (high cut / RPFT), Domain II — Procedures includes diffusing capacity. Task II.A.9 expects you to select the correct DLCO pathway and hardware for the order and patient. High-cut items rarely stop at “what is DLCO?” They present an order (e.g., “complete PFTs including DLCO,” “DLCO only after recent smoke exposure,” “patient on continuous O₂”) and ask which protocol, gas mixture concept, interface, or pre-test constraint applies.

Section 10.1 is the decision layer before coaching the maneuver (10.2) and grading validity (10.3). Domain I instrument calibration is assumed complete; here the question is which DLCO method to run, which circuit components to choose, and which patient conditions must be controlled before the first test-gas breath.

Diffusing capacity of the lung for carbon monoxide (DLCO)—also called transfer factor (TLCO) in some regions—quantifies the rate at which CO moves from alveolar gas into blood, reflecting alveolar–capillary membrane area and thickness, pulmonary capillary blood volume, and reaction with hemoglobin. It is reported in traditional units (mL/min/mmHg) or SI units (mmol/min/kPa). Clinical questions include interstitial lung disease, emphysema/pulmonary vascular disease, anemia/polycythemia effects, and monitoring of drug toxicity (e.g., amiodarone, chemotherapy)—but II.A.9 is about selecting and equipping the test, not writing the full Domain III interpretation paragraph.

Single-breath DLCO (DLCO-SB) as the standard protocol

Unless the order or patient capability forces another path, clinical laboratories select single-breath DLCO (DLCO-SB) as the default:

1. Patient exhales unforced to near residual volume (RV).
2. Rapidly inspires a measured test-gas mixture to near total lung capacity (TLC).
3. Holds breath for about 10 seconds (standards window discussed in 10.2).
4. Exhales; the system discards a washout volume and analyzes an alveolar sample for CO and tracer.
5. Software computes DLCO (and often VA, DLCO/VA or KCO) from inspired and alveolar gas concentrations, breath-hold time, and inspired volume.

Why SB is standard: it is widely standardized (ATS/ERS technical standards concepts), relatively quick, and yields both transfer factor and an estimate of alveolar volume from the inert tracer dilution—provided the patient can achieve a near-TLC inspiration and a stable breath-hold.

When alternatives may be considered

Exam trap: Choosing “rebreathing DLCO for every dyspneic patient” is wrong. Alternatives exist for special populations and research, but II.A.9 selection for routine RPFT practice centers on DLCO-SB and the conditions that make SB feasible.

Inspired gas mixture concepts

The single-breath inspired mixture is not plain air. It is a calibrated test gas designed so two parallel processes can be measured: CO uptake and tracer dilution (to estimate alveolar volume and correct for dilution).

Components (conceptual)

Exact commercial blends vary by manufacturer; the RPFT must know function, not memorize every cylinder label. Key ideas:

• CO is present in small concentration—enough for analysis, low enough for safety when trial limits are respected.
• The tracer must be essentially insoluble and non-reactive so its concentration change reflects dilution, not uptake.
• Inspired O₂ should be consistent with the lab’s reference equations and prior tests; testing a patient still breathing high FiO₂ without protocol adjustment confounds comparison.

Cylinder, demand, and purity selection notes

• Use manufacturer-specified certified test-gas cylinders or blended systems; do not substitute arbitrary CO mixtures.
• Confirm cylinder pressure and expiration/certification before the session.
• Select the correct analyzer channels for the tracer your gas actually contains (He vs CH₄)—mismatched tracer selection is a setup error under II.A.9.
• Ensure water vapor and CO₂ handling matches the analyzer design (absorbers upstream of sensors, or analyzers with built-in correction). Wrong gas conditioning changes reported fractions.

Equipment selection for DLCO-SB (II.A.9)

Protocol selection is inseparable from circuit hardware. Even perfect coaching fails if the demand system, analyzers, or patient interface are wrong.

Demand valve and bag/reservoir

• Demand valve systems deliver test gas on inspiration with minimal resistance when the patient inspires forcefully to TLC.
• Bag-in-box or reservoir bag systems present a known volume of test gas for the inspiratory vital capacity maneuver.
• Select a system with adequate reservoir volume for the patient’s expected VC; an empty bag mid-inspiration truncates VI and ruins the trial.
• Valving must switch cleanly between room air (or medical air), test gas, and sample/exhalation paths without cross-leak that dilutes CO or tracer.

Volume measurement

• A calibrated spirometer / flow sensor measures inspired volume (VI) and expired washout/sample segments.
• Volume accuracy links DLCO to percent of VC inspired—a validity cornerstone in 10.3—so select a device still within Domain I calibration limits.

Analyzers

Analyzers must be zeroed and spanned per IFU before patient testing (Domain I carry-forward). Selecting a DLCO protocol on a system whose CO channel failed span is a selection/QC failure, not a coaching problem.

Absorbers and gas conditioning

• Water absorbers (e.g., Nafion or chemical driers, system-dependent) and/or CO₂ absorbers may sit in sample lines so infrared or other sensors see dry, CO₂-controlled gas as designed.
• Exhausted soda lime or water traps that saturate or channel produce drifting readings—replace per schedule before calling the circuit “ready.”
• Know whether your system uses absorbers versus mathematical correction; you still select a dry, patent sample path free of condensate.

Mouthpiece, filter, and nose clip

• Bacterial/viral filter validated for DLCO (dead space and resistance within manufacturer limits).
• Tight-seal mouthpiece; flanged pieces for edentulous patients if they maintain seal at TLC.
• Nose clip mandatory—nasal leak during breath-hold dilutes alveolar sample with room air and lowers apparent DLCO / distorts VA.
• Support arm or tubing so the patient does not pull the mouthpiece out during the 10-second hold.

Related equipment choices tied to the order

Exam trap: “Any spirometer mouthpiece without a nose clip is fine for DLCO.” Breath-hold with nasal leak is a classic invalid setup.

Pre-test conditions that belong in II.A.9 selection

Selecting DLCO includes deciding whether the patient is ready and what must be documented before the first CO inhalation.

Smoking and COHb

• Cigarette smoke elevates carboxyhemoglobin (COHb), which reduces measured DLCO (less available Hb binding sites; back-pressure effects in calculation concepts).
• Advise patients not to smoke on the day of testing; many labs request longer abstinence when feasible. ATS/ERS-aligned practice emphasizes avoiding smoking before DLCO.
• At check-in, ask and document last smoke/vape time. If the patient smoked recently, selection options include proceed with documentation, defer, or obtain COHb if lab policy uses measured COHb for adjustment—follow medical-director SOP rather than inventing a home-made correction factor on the fly.

Supplemental oxygen

• High inspired O₂ increases competition at the Hb binding site and can lower measured DLCO relative to room-air testing.
• When safe and ordered as room-air DLCO, discontinue supplemental O₂ for a documented interval before testing (labs commonly use on the order of 10–15 minutes of room air if the patient tolerates it—confirm local policy and SpO₂ safety limits from Chapter 7 concepts).
• If the patient cannot come off O₂, select whether to defer, test on O₂ with clear labeling, or obtain clinician guidance. Silent testing on 4 L/min nasal O₂ while comparing to prior room-air DLCO is a selection error.

Recent exercise

• Heavy exercise shortly before DLCO can alter pulmonary blood volume and ventilation distribution.
• Instruct patients to avoid vigorous exercise before the visit when possible; allow quiet rest in the lab before the first trial.
• Do not run DLCO immediately after a maximal CPET without a recovery plan if both are ordered the same day—sequence per lab protocol.

Hemoglobin availability for correction

Measured DLCO varies with hemoglobin concentration. Standards and reporting practice commonly include Hb-corrected DLCO when a recent Hb is available:

• Anemia → lower uncorrected DLCO; correction raises the value toward what it would be at standard Hb.
• Polycythemia → higher uncorrected DLCO; correction adjusts downward.

Selection implication (II.A.9): before calling the study “complete for interpretation,” verify that a recent Hb (same day or within lab policy window) is available or ordered. If Hb is missing, you may still perform technically valid maneuvers, but the report pathway should flag uncorrected values. RPFT stems often ask whether to obtain Hb rather than release a naked number in a clearly anemic patient.

Other pre-test logistics

• Avoid heavy meals immediately before testing if they limit deep inspiration.
• Loose clothing; remove restrictive garments.
• Review contraindications shared with forced maneuvers (e.g., recent eye/thoracic/abdominal surgery, unstable cardiovascular status, active hemoptysis)—DLCO requires deep inspiration and breath-hold.
• Confirm the patient can follow multi-step instructions; arrange interpreter or simplified coaching plan if needed.

Check-in verification checklist (exam-ready)

1. Confirm identity, order includes DLCO, and no legal/clinical hold.
2. Document smoking, O₂ use, last exercise, medications relevant to testing day.
3. Confirm Hb plan for correction.
4. Select DLCO-SB vs escalate alternative only if indicated.
5. Verify test-gas type matches analyzer configuration (He vs CH₄ tracer).
6. Confirm demand/reservoir, absorbers, filter, mouthpiece, nose clip ready.
7. Confirm instrument QC/calibration current (Domain I) before first trial.

Mapping orders to protocol choices (II.A.9)

Integration with infection control and QC

Disposable filters between patients, no testing after failed analyzer span, and cylinder integrity checks remain mandatory. Selecting DLCO on an exhausted CO₂ absorber or empty test-gas bag wastes CO exposure and patient effort.

RPFT decision scenarios

Scenario A: Order: DLCO. Patient arrived on 3 L/min O₂, SpO₂ 96% on O₂, 88% after 2 minutes room air with distress. Selection: do not force prolonged room-air deprivation; contact ordering pathway; if test proceeds on O₂, label FiO₂/flow and document limitation—do not pretend the value matches prior room-air DLCO without comment.

Scenario B: Cylinder is methane-tracer mix; software still set to helium. Selection/setup error: correct tracer configuration before any patient trial.

Scenario C: Severely anemic patient, Hb 7.8 g/dL drawn this morning, order “DLCO.” Select standard DLCO-SB and ensure Hb correction will be applied in reporting—not raw DLCO alone as if Hb were normal.

Link forward

Once protocol, gas, equipment, and pre-test conditions are selected and documented, Domain II.B.9 requires you to perform the single-breath maneuver with correct timing, washout, and sample collection (section 10.2). Domain II.C.9 then grades inspired volume, breath-hold, sample quality, and repeatability (section 10.3).